Interview guides · Fresenius Medical Care North America

Fresenius Medical Care North America Data Scientist Interview Questions & Guide 2026

Practice explaining analysis before a Fresenius Medical Care North America data scientist interview: the recommendation, the uncertainty, the follow-ups.

The 60-second brief

As a Data Scientist at Fresenius Medical Care North America, you are at the intersection of advanced analytics and life-critical healthcare. You will play a vital role in transforming complex medical and operational data into actionable insights that directly improve the lives of patients suffering from renal disease and other chronic conditions. Your work informs clinical decision-making, optimizes resource allocation, and enhances the overall efficiency of Fresenius Medical Care North America's care delivery networks.

How much statistics you need depends on the flavour of the seat. Experiment-facing work wants you deep enough to notice that repeated looks at accumulating data inflate the false positive rate of a fixed-sample test; modelling-facing work wants estimation and honest uncertainty intervals.

Focus areas

Correct for claims runout before reporting recent months
Build member-month denominators from overlapping coverage spans
Minimise protected health information in every extract

Overview

The environment here is defined by high-impact, mission-driven work. You will collaborate with cross-functional teams—including clinicians, marketing strategists, and engineering experts—to tackle problems that are not just technically challenging, but socially significant. Success in this role requires a blend of rigorous analytical capability and the communication skills necessary to translate technical findings for stakeholders who are focused on patient outcomes and operational excellence.

Where to focus your preparation

Treat the sections below as preparation areas and confirm the format with your recruiter.

Preparation focus

No round sequence has been reported for this company, so work the categories below and confirm the format with your recruiter.

What to demonstrate

Breadth across SQL, experimentation and product reasoning
Ability to state assumptions before choosing a method

How to prepare

Drill the practice exercises below and time yourself
Prepare three quantified stories about decisions you drove

Where candidates lose points

Rates built on member counts rather than exposure

Members join and leave mid-period, so dividing events by distinct members mixes a person covered for 30 days with one covered for 365. New joiners also have artificially low observed utilisation because their claims have not arrived yet and because care takes time to initiate. Denominators must be member-months or member-years, and comparative quality measures usually need a continuous-enrolment requirement with an explicit allowable gap, stated in days.

Treating clinical measurements as missing at random

A lab result, a vital sign, or a screening exists because someone ordered it, and ordering tracks suspicion of disease, visit frequency, and site workflow. Imputing the mean or dropping incomplete rows biases the population estimate and can flip the sign of an association, because the untested are systematically healthier or systematically disengaged. The presence indicator is often more predictive than the value, which is a warning sign rather than a feature win: a model that learns test ordering will not transfer to a site with different protocols.

Sizing estimates built on unnamed, unrevisable assumptions

Write each assumption as a named number you can change, then show the arithmetic so the interviewer can challenge one input instead of the whole answer. Finish by saying which assumption the result is most sensitive to, which matters more than the point estimate.

Optimising accuracy on a heavily imbalanced target

State the base rate first, then choose the metric from the relative cost of a false positive against a false negative: precision and recall at the operating threshold, PR-AUC, or expected cost. At a 1 percent positive rate, predicting the majority class for everyone scores 99 percent accuracy and is worthless.

Questions & practice

What is your preferred approach for validating model performance in a clinical setting?

Medium · machine learning and modelling

Approach

Say how the offline result would be validated online before it is trusted.
Frame the prediction: the label, the moment of prediction, and the action it triggers.
Set a baseline first, so any model has something honest to beat.

Follow-up

Where could label leakage enter this setup?
How would you choose the decision threshold, and who owns that choice?

How have you previously translated a business requirement into a technical data model?

Medium · machine learning and modelling

Approach

Check what information would not exist at prediction time, and exclude it.
Pick an evaluation metric that matches the cost of each error type, not a default.
Say how the offline result would be validated online before it is trusted.

Follow-up

What would you monitor after launch to know the model is still valid?
Where could label leakage enter this setup?

Sessionise transfer chains into episodes, then count readmissions

Hard · sessionisation · cumsum grouping · readmission

encounter has encounter_id, patient_id, facility_id, encounter_type, admit_ts, discharge_ts, admission_type, discharge_disposition, is_planned_admission, principal_diagnosis_code. Chain acute-to-acute transfers into episodes of care: an inpatient encounter discharged as transfer_acute, followed by another inpatient encounter for the same patient at a different facility admitting within 24 hours of that discharge, belongs to the same episode. Then compute the 30-day unplanned readmission rate over episodes, excluding index episodes that are planned, that end in expired, hospice or against medical advice, or that are still open. Return encounter_id to episode_id, plus the rate.

Approach

Restrict to inpatient encounters for the chaining step and sort by patient_id, admit_ts. Observation and emergency encounters are not acute inpatient stays and pooling them changes both the chain and the denominator.
Build a boolean continues flag: the previous row is the same patient, its discharge_disposition is transfer_acute, its facility_id differs from this row's, and admit_ts minus previous discharge_ts is between 0 and 24 hours. Episode id = cumsum of the negation of that flag. This is the vectorised form of a sessionisation loop and is why the pattern generalises to any event stream.
Collapse to episode grain taking first admit_ts, last discharge_ts, last discharge_disposition, and any() of is_planned_admission. The episode inherits its exit state, not its entry state, which is why a transfer chain ending at home is one home discharge rather than two transfers.
Apply index exclusions at episode grain. Dropping episodes that end in death is not optional: a dead patient cannot be readmitted, so leaving them in inflates the denominator and depresses the rate for exactly the panels caring for the sickest members.
For each surviving index episode, find the next unplanned acute inpatient episode for that patient admitting within 30 days of the index discharge_ts. Count events at episode grain, since one patient can contribute several index episodes. Report the raw rate and say plainly that it is not comparable across panels without risk adjustment, which is what the observed-over-expected form exists for.

Worked solution (45 min)

Filter to encounter_type 'inpatient', sort by patient_id and admit_ts, and shift discharge_ts, discharge_disposition, facility_id and patient_id by one row.
Compute continues as same patient AND prior disposition is transfer_acute AND facility differs AND 0 <= (admit_ts - prior discharge_ts) <= 24 hours; episode_id = (~continues).cumsum().
Aggregate to episodes: first admit_ts, last discharge_ts, last discharge_disposition, any planned flag, patient_id.
Drop index-ineligible episodes: planned, disposition in expired, hospice or ama, and null discharge_ts.
For each eligible index episode, search the same patient's later episodes for an unplanned admit_ts within 30 days of index discharge_ts; a merge_asof on patient with a forward direction and a 30-day tolerance does this without a nested loop.
Rate = index episodes with an event divided by eligible index episodes; return the encounter-to-episode map alongside it.

Expected result: Two outputs: an encounter_id to episode_id map, and one rate. Worked case: encounter A discharged transfer_acute at 10:00, encounter B admitted 14:00 the same day at a different facility and discharged home on day 5, encounter C an unplanned admission on day 20. A and B form one episode, C is a readmission of it, and the patient contributes one eligible index episode and one event, not two indexes and possibly two events.

Verify it yourself

Every closed episode ends in a disposition other than transfer_acute; an episode ending in transfer_acute means a chain was cut early.
Episode count is less than or equal to inpatient encounter count, with equality only when the sample contains no transfers.
Turning the chaining rule off raises the readmission rate. The direction of that change is the proof your chaining fired at all.
No index episode's matched readmission is an encounter already inside that same episode.

Follow-up

discharge_ts is null on an open stay in the middle of a chain. What does your flag do, and what should it do?
A patient is transferred out and then back to the originating facility within 24 hours. Should that chain, and does your facility_id condition handle it?
Is a readmission itself eligible to serve as a later index episode? Say what you chose and what the choice does to the rate.

Deduplicate claim versions before totalling allowed amounts

Easy · dedup · window functions · claim versions

medical_claim_line holds one row per service line per claim version: claim_line_id, claim_id, claim_version, frequency_code (1 original, 7 replacement, 8 void), member_id, service_start_date, procedure_code, allowed_amount, claim_status and adjudicated_at. Adjusted claims appear more than once, so summing every row double counts them. Return total allowed_amount by procedure_code for service_start_date in Q1 2025, counting only lines with claim_status 'paid' on the surviving version of each claim, which is the highest claim_version per claim_id, and dropping the claim entirely when that surviving version carries frequency_code 8. Resolve survivorship with a window function, not a self-join.

Approach

Resolve survivorship at claim_id, not claim_line_id. Carry MAX(claim_version) OVER (PARTITION BY claim_id) alongside every line and keep lines where claim_version equals it, because a replacement version can contain a different number of lines than the original.
Read the frequency_code of the surviving version only. A frequency_code 8 removes the claim outright; it does not revert payment to the prior version, so a void must delete the claim rather than promote version n-1.
Apply claim_status and the date filter after survivorship is resolved. Filtering paid lines first can strip the surviving version and silently elect a superseded one.
Group by procedure_code and sum allowed_amount, then state the paid-through date on the output because Q1 amounts keep moving until adjudication runout completes.
Sanity check the shrinkage: report how many claim_ids and how many dollars the dedup removed, so the reviewer can see the step did something.

Follow-up

Two rows share a claim_id and claim_version but differ on adjudicated_at. What do you do, and what does that imply about the extract?
How does the query change if the request is allowed_amount by paid_date rather than service_start_date, and which basis does a finance reconciliation want?
A void arrives for a claim already published in a closed month. How do you restate without rewriting history in the warehouse?

Turn overlapping coverage spans into fractional member-month denominators

Medium · intervals · gaps and islands · denominators

member_enrollment holds span_id, member_id, plan_id, product_type, effective_date and termination_date, which is NULL while the span is active. A member can hold several spans in a year, and back-dated plan changes make spans overlap. Return one row per calendar month of 2025 with total member-months, where a member contributes covered days in the month divided by that month's length, and a day covered by two overlapping spans counts once. Both span endpoints are inclusive. Collapse overlaps with window functions before joining a month calendar, and do not assume one span per member.

Approach

Normalise the open end first. COALESCE(termination_date, DATE '9999-12-31') or clip to the reporting end, because a NULL termination_date makes every BETWEEN comparison unknown and drops exactly the members who are still covered.
Merge overlapping spans per member before the calendar join. Order by effective_date, carry a running MAX of prior termination_date with a frame ending one row before, and open a new island where effective_date exceeds that running max plus one day, which keeps adjacent spans contiguous rather than splitting them.
Clip each merged island to the reporting year, then cross join to a twelve-row month calendar and keep pairs that intersect.
Compute covered days as LEAST(island_end, month_end) minus GREATEST(island_start, month_start) plus one, and divide by the actual length of that month rather than a flat 30, so February and the 31-day months are not distorted.
Sum the fractions by month. Merging after the calendar join also works but forces a DISTINCT over member-days, which stops scaling at population size.

Worked solution (30 min)

CTE bounded: clip spans to 2025-01-01 through 2025-12-31 with COALESCE on termination_date, discarding spans that do not intersect the year.
CTE merged: gaps-and-islands per member using LAG and a running MAX over preceding rows to collapse overlapping and adjacent spans.
CTE months: twelve rows of month_start, month_end and days_in_month.
Join merged to months on interval intersection and compute covered_days per pair.
SUM(covered_days / days_in_month::numeric) grouped by month, ordered by month.

Expected result: Twelve rows of (month, member_months) with fractional values. Any single member contributes at most 1.0 to a month and at most 12.0 across the year. A member covered 2025-01-01 through 2025-02-20 contributes 1.0 in January and 20/28 = 0.714 in February.

Verify it yourself

For a member with spans 2025-01-01..2025-03-31 and 2025-03-15..2025-06-30, March contributes exactly 1.0, not 1.5.
Total member-months is at most 12 times COUNT(DISTINCT member_id) and at least the count of members covered the whole year.
Forcing every termination_date to NULL raises the total. If it drops to zero, the NULL handling is missing.

Follow-up

Where does a continuous-enrolment filter with an allowable 45-day gap belong, and how does that change the island boundary rule?
One human appears under two member_ids after a master person index merge. What does that do to member-months, and how would you detect it?
How do you treat a span that terminates on the day it starts, and what does that row usually represent?

Can you walk us through your past experience with predictive modeling?

Medium

Approach

Work from the decision backwards to the evidence you would need.
Say what you would check first and why it is the highest-information step.
State your assumptions explicitly before working the problem.

Follow-up

What assumption would you test first?
How would you know your answer was wrong?

Estimate a programme effect at a fixed risk-score enrolment cutoff

Medium · regression discontinuity · regression to the mean · local average treatment effect

Care management enrols members whose prospective_risk_score in member_enrollment crosses a fixed annual threshold of 1.75; above the line enrolment is near-automatic and below it unavailable, and about 85 percent of members above the line actually enrol. Leadership refused a randomised holdout and wants the programme's effect on next-year allowed PMPM. Two years of scores and claims are available. State the design, the estimand it identifies, the assumptions, and the diagnostics you would run before reporting anything.

Approach

Propose a fuzzy regression discontinuity on prospective_risk_score at 1.75. Uptake jumps but is not complete, so the estimator is the ratio of the jump in outcome to the jump in enrolment probability at the cutoff, which is a Wald ratio.
State the estimand honestly up front: a local effect for members near 1.75, who are the least sick enrollees. It does not identify the effect on the top risk decile, which is usually the number leadership actually wants, and saying so before the result lands is what keeps the analysis credible.
Say explicitly why the obvious alternative fails. A pre-post on enrolled members selects on a high score in year one, and such cohorts regress toward the mean in year two whether or not anything is done, so a pre-post design reports savings every time. The discontinuity is immune because it compares members on either side of an arbitrary line.
Specify the estimation: local linear fits on each side, triangular kernel, a data-driven MSE-optimal bandwidth, and robust bias-corrected inference rather than a naive local-linear confidence interval. Do not fit a high-order global polynomial.
Run the falsification suite before looking at the effect: a density test for manipulation of the running variable, continuity of pre-determined covariates at the cutoff, sensitivity across bandwidths, and placebo cutoffs away from 1.75.

Worked solution (30 min)

Plot the outcome and the enrolment rate against the centred running variable in uniform bins to confirm a visible jump in both.
Estimate the first stage (jump in enrolment probability at 1.75) and the reduced form (jump in next-year PMPM), then take the ratio for the fuzzy RD estimate.
Select the bandwidth by an MSE-optimal rule with a triangular kernel and local linear fits, and report robust bias-corrected intervals.
Run the density test at 1.75 and the covariate continuity tests on age, prior-year cost, dual_eligible_flag, and product_type.
Re-estimate at 0.5x, 1x, and 2x the selected bandwidth, and at placebo cutoffs of 1.50 and 2.00.

Expected result: A fuzzy RD estimating a local average treatment effect on compliers near the 1.75 cutoff, equal to the outcome jump divided by the enrolment jump, with local linear fits, a triangular kernel, an MSE-optimal bandwidth, and robust bias-corrected inference. The result is explicitly not generalisable to the highest-risk members.

Verify it yourself

The density test should show no discontinuity at 1.75; a spike just above the line indicates manipulation and invalidates the design.
Pre-determined covariates should show discontinuities indistinguishable from zero at the cutoff.
The point estimate should be stable across 0.5x, 1x, and 2x bandwidth.
Placebo cutoffs away from 1.75 should return null effects.

Follow-up

Risk scores are built from coded diagnoses, and coding intensity is something people can influence. What would manipulation look like in the density, and what do you do if you see it?
The MSE-optimal bandwidth leaves 900 members. How do you decide whether to report an underpowered estimate at all?
Design an encouragement version instead: randomise the invitation rather than enrolment. What does instrumental variables buy you, and which assumption is most at risk?

Adherence share collapsed the month a feed was added

Easy · pdc · interval sql · identity resolution

The share of members with proportion of days covered at or above 0.80 in one therapeutic class fell from 0.71 to 0.58 in a single month. pharmacy_claim carries fill_id, member_id, ndc_code, therapeutic_class_code, fill_date, days_supply, quantity_dispensed, refill_number, reversal_flag, reversed_fill_id and source_system_code. There is no person-level key above member_id and no enrollment table on hand, so every diagnostic has to run on pharmacy_claim alone. That month the pipeline began ingesting a second pharmacy source. Determine whether adherence actually changed, and hand back a PDC query you would defend line by line.

Approach

Compute controls that depend on neither member identity nor the PDC code: total fills in the class per month, and total days_supply dispensed in the class per month. Both are sums over rows, so neither moves when one person's fills split across two member_ids, which is exactly what a per-member control cannot promise. If both are flat while PDC falls, no dispensing behaviour changed and the computation or the keys did.
Check days_supply for nulls and zeros by source_system_code. If the new source omits days_supply and the code coalesces null to zero, covered days vanish and PDC falls even though the fills are there.
Check for member identity splitting using the columns you actually have. There is no person key above member_id, so the split has to be found by its footprint: distinct member_id in the class jumping at the break while total fills stay flat, and a rise in the share of member_ids whose earliest fill for a given ndc_code carries refill_number above zero, which is a continuation history that lost its beginning. When one person is split, each id may fall below the two-fill denominator requirement and drop out, and the ids that do survive carry artificial gaps.
Check reversals. A reversed fill is two rows, the fill and a row with reversal_flag TRUE pointing at reversed_fill_id, and both must be excluded from exposure. If the new source expresses reversals differently and reversed_fill_id does not link, phantom coverage appears, which pushes PDC up rather than down, so use this to rule the cause in or out.
Verify the denominator and window are unchanged: members with at least two fills in the class and at least 91 days of follow-up, over a stated fixed 12-month window, never a mixture of window lengths.
Write the PDC query so overlapping refills shift the next interval's start to the later of fill_date and the prior interval's end, so a day is covered at most once, and cap at one day per calendar day.

Follow-up

Why is PDC preferred to medication possession ratio when early refills are common?
You want to compare adherent and non-adherent members on hospitalisation. What is wrong with classifying on a 12-month PDC and then following from day zero?
A member switches to a different drug in the same class mid-year. How does your interval logic handle that, and is the class the right grain?

Suggested practice checklist

For a candidate whose interviews will centre on A/B testing, metric movement and causal claims. Design comes before arithmetic, arithmetic before analysis, and the week ends by rehearsing the readout rather than the derivation.

Day 1 — Design one test end to end on paper

Take a single feature change and write the full design: randomization unit, the exact point of exposure, the primary metric with its grain, guardrails, allocation, planned duration, and the decision rule committed before any data exists.
Write why the randomization unit must sit at or above the level where treatment can spill over, and give one case where user-level randomization is still contaminated (shared accounts or devices, or two participants in the same marketplace).
State in advance what you will do if the primary metric is flat while a secondary metric is significant.

Deliverable: A one-page test design with a decision rule written before launch.

Day 2 — Power arithmetic until it is automatic

Compute required sample size per arm for a binary metric with the normal approximation, n is approximately 2 times (z for alpha/2 plus z for power) squared times p(1 minus p) divided by delta squared, for baselines of 2, 10 and 40 percent at a 5 percent relative lift, and note that for a fixed relative lift the requirement falls as the baseline rises because delta grows proportionally with p.
Redo the calculation for a continuous metric using variance in place of p(1 minus p), and show why a heavy-tailed quantity such as revenue per user needs either far more traffic or a capped version with a stated cap.
Convert one of the results into weeks given a weekly eligible traffic figure, then list the two honest ways to shorten it (accept a larger detectable effect, or reduce variance) and write why quietly lowering the power target is a decision to miss more real wins, not a speedup.

Deliverable: A small script or sheet that maps baseline, minimum detectable effect, alpha and power to sample size and weeks, cross-checked against a published calculator.

Day 3 — Variance and the unit-of-analysis problem

Take a ratio metric whose denominator is not the randomization unit (clicks per session, randomized by user) and compute the standard error twice, once naively at session level and once by the delta method or a user-level bootstrap, then record how much the naive version understates it.
Implement CUPED on simulated data: choose a pre-period covariate X measured before assignment, estimate theta as Cov(Y, X) divided by Var(X), and analyse Y minus theta times (X minus its mean) in place of Y. Confirm the variance of the adjusted outcome equals the raw variance multiplied by one minus the squared correlation between Y and X, so a correlation of 0.45 removes about 20 percent of the variance and not 80.
Now run that simulation a few hundred times and confirm the adjusted effect estimate is unbiased for the same effect rather than numerically identical to the raw one. Within any single run the two differ, sometimes by a large fraction of the true effect, because the two arms' pre-period covariate means never coincide exactly in a finite sample; they agree in expectation, which is the property that matters and the one to state out loud.

Deliverable: A notebook showing the adjusted estimator with a measurably smaller variance than the raw one, plus a repeated-simulation table showing the two estimators agreeing on average while differing run by run.

Day 4 — Validity threats you can actually test for

Run a sample ratio mismatch check as a chi-square goodness-of-fit test against the intended allocation, and write the three causes you would chase first (assignment logged before exposure, an arm-specific redirect or load failure, bot filtering applied asymmetrically).
Simulate peeking: generate A/A data, test daily at alpha 0.05 across 14 looks, record the inflated false positive rate, then apply an alpha-spending boundary or commit to a fixed horizon and confirm the rate returns to nominal.
Write how you would separate a novelty effect from a durable lift using the treatment effect plotted against days since first exposure, and what shape would change your recommendation.

Deliverable: One table showing the peeking false positive rate before and after correction, plus a written SRM triage list.

Day 5 — When randomization is not available

Write the identifying assumption for difference-in-differences (parallel trends in the absence of treatment), then plot pre-period trends for two candidate control groups and justify rejecting one of them.
Design a switchback test for a change where user-level randomization would leak across participants, choosing a time-block length against the carryover you expect and saying how you would detect carryover in the data.
List what an interrupted time series or a synthetic control buys you and the one thing neither can rule out: an unobserved shock that coincides with the launch.

Deliverable: A one-page memo recommending a single quasi-experimental design and naming its weakest assumption explicitly.

Day 6 — The readout query

Write the assignment-to-exposure join that returns exactly one row per unit per experiment, and handle units appearing in both arms by excluding and counting them rather than silently keeping one.
Compute the per-arm metric, its variance and the relative lift with a confidence interval in SQL, then reproduce the identical numbers in a notebook as a cross-check.
Add a segment breakdown and write the sentence that keeps it from being p-hacking: segments declared in advance, everything else reported as exploratory and corrected for multiplicity.

Deliverable: A single query that outputs the full readout table, matched to a notebook recomputation.

Day 7 — Present it to someone who will not read the appendix

Give a 10-minute readout of a real or simulated experiment in the order decision, number, uncertainty, caveat.
Have your listener ask "can we ship it" in the case where the primary is flat and a guardrail moved, and answer with a recommendation rather than a request for more data.
Rewrite your opening line so the recommendation lands before any methodology.

Deliverable: A one-page readout whose first line is the recommendation.

Being wrong in public

A number you shipped turned out to be wrong, and someone had already acted on it. That is one of the most useful stories a data person can carry. What is being scored is how fast you noticed, who you told first, and what you changed in the process so the same class of error could not repeat quietly.

How do you handle missing or noisy data in a healthcare context?

Medium · behavioural and stakeholder questions

Approach

Name the disagreement or constraint, and how you resolved it with evidence.
Quantify the outcome, including what you would not claim credit for.
Pick a story where you drove the decision, not one where you observed it.

Follow-up

What would you do differently if you ran that project again?
What did you decide not to do, and why?

Can you describe your experience working within a multi-disciplinary team?

Medium · behavioural and stakeholder questions

Approach

Close with what you would do differently, concretely.
Pick a story where you drove the decision, not one where you observed it.
Name the disagreement or constraint, and how you resolved it with evidence.

Follow-up

How did you know the outcome was caused by your change?
What would you do differently if you ran that project again?

Describe a time you had to explain a complex statistical finding to a non-technical stakeholder.

Medium · behavioural and stakeholder questions

Approach

Pick a story where you drove the decision, not one where you observed it.
Name the disagreement or constraint, and how you resolved it with evidence.
Close with what you would do differently, concretely.

Follow-up

How did you know the outcome was caused by your change?
What would you do differently if you ran that project again?